Info

Psychedelics Today

Psychedelics Today is the planetary leader in psychedelic education, media, and advocacy. Covering up-to-the-minute developments and diving deep into crucial topics bridging the scientific, academic, philosophical, societal, and cultural, Psychedelics Today is leading the discussion in this rapidly evolving ecosystem.
RSS Feed Subscribe in Apple Podcasts
Psychedelics Today
2024
November
October
September
August
July
June
May
April
March
February
January


2023
December
November
October
September
August
July
June
May
April
March
February
January


2022
December
November
October
September
August
July
June
May
April
March
February
January


2021
December
November
October
September
August
July
June
May
April
March
February
January


2020
December
November
October
September
August
July
June
May
April
March
February
January


2019
December
November
October
September
August
July
June
May
April
March
February
January


2018
December
November
October
September
August
July
June
May
April
March
February
January


2017
December
November
October
September
August
July
June
May
April
March
February
January


2016
December
November
October
September
August
July
June
May


Categories

All Episodes
Archives
Categories
Now displaying: November, 2016
Nov 30, 2016
  15310426_10207900312889025_1816221621_n Download Joe and Kyle talk to Shannon Clare Petitt about the current state of MDMA research and what MAPS needs to do in the next number of months with the FDA as the phase three trials become approved. A few days after the interview the New York Times reported that the phase three research was approved. Shannon's story is great and optimistic. If you are interested in how to get a job in the psychedelic field, this is certainly an episode you'll want to listen to. We also discuss some possible tweaks to the studies that could be done that may yield interesting results, and also why MAPS is taking the approach that they are (its the most straightforward way to push the research through the FDA). wallpaper-zendo-bm   Here is Shannon's bio from the MAPS staff page.

Shannon Clare Petitt, M.A., MFTI, Therapist Training Program Coordinator and Zendo Project Community Engagement Coordinator

Shannon received her Master’s in Integral Counseling Psychology from the California Institute of Integral Studies in 2014, with a practicum working with youth on moderation management for drug and alcohol use. Her passions include working with addiction, trauma, relationship, the body, and nature. At the Multidisciplinary Association for Psychedelic Studies she serves as the Therapist Training Program Coordinator. She also leads Community Engagement for the Zendo Project, bringing harm reduction services to events and expanding efforts for awareness and integration of psychedelic experiences. Shannon is a co-therapist in a MAPS-sponsored Phase 2 trial researching MDMA-assisted psychotherapy for anxiety associated with life-threatening illness. She is a California native and can be found running outdoors anywhere she travels, dancing to the beat, and jumping in the ocean when she gets the chance!
Links Psychedelic Salon Podcast Featuring Shannon, Rick Doblin and Annie Oak Zendo Project MAPS https://www.youtube.com/watch?v=nDzwFRbV9gg
Nov 22, 2016
Download Faan was a great guest. He is currently working on a cannabis startup in Montréal, Québec, Canada named Indeeva Biomedical. Joe previously interviewed Faan for his permaulture podcast Permaculture Salad to talk about how shamanism, ayahuasca and permaculture go together in a complementary way (link). At the time of that interview Faan was living on a permaculture/ayahuasca retreat center in Peru named the Paititi Institute. Faan now lives in Montréal and has studied at McGill University where he studied cubic farming methods, which is one of many ways to decrease the total carbon output of agriculture. [caption id="attachment_317" align="alignright" width="255"]Cannabis from Backcountry Cannabis Photo via Backcountry Cannabis[/caption] I hope you find his insights as interesting as we did. Feel free to reach out with any questions through our contact page or reach out to Faan via LinkedIn or Twitter - links below. In this interview we speak at length about number of subjects including:
  • Cannabis
  • CBDs
  • Opiates
    • Fentanyl
    • Addiction
  • Ayahuasca
  • Pharmahuasca
    • To what degree is Pharmahuasca different from Ayahuasca in terms of effect
  • Novel applications of drugs for specific diseases/conditions
  • Speculations about future cannabis laws in Canada
  • Synergistic qualities of cannabis.

 Links

https://www.medicaljane.com/directory/professional/faan-rossouw/ https://www.linkedin.com/in/faan-rossouw-73961b96 https://twitter.com/brah_faanicus https://www.facebook.com/indeevabm http://permaculturesalad.com/faan-rossouw-episode-7-amazonian-permaculture/ Aug 2013 interview Cannabis + Poppies
Nov 15, 2016
Download Kyle recently had the great opportunity to attend one module of the MAPS MDMA Therapy sessions. In this episode we talk about the experience at the workshop and about some other valuable topics as well. Let us know what you think, and please leave a review on iTunes!
  • Details on Phase Three studies for MDMA therapy
  • Oceanic\Manic symptoms vs "real" mania
  • Patients expressing religious material showing up in sessions
  • Measurement tools (CAP Score)
  • Similarities between this MAPS method and the Grof model
  • MDMA taking down the fear response and allowing patients to access difficult material
  • Watching hours of video as a training method for MDMA psychotherapy
  • Timelines for legalization
  • How to apply the scientific method to the music used in MDMA therapy
  • How to get ready for the legalization for MDMA therapy
Kyle Buller - Psychedelics Today    
1